• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过ATP-STD核磁共振光谱法筛选蛋白激酶。

Screening of protein kinases by ATP-STD NMR spectroscopy.

作者信息

McCoy Mark A, Senior Mary M, Wyss Daniel F

机构信息

Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, USA.

出版信息

J Am Chem Soc. 2005 Jun 8;127(22):7978-9. doi: 10.1021/ja0425942.

DOI:10.1021/ja0425942
PMID:15926798
Abstract

ATP-STD NMR takes advantage of Mg2+ binding to ATP to adjust the ATP affinity for protein kinases permitting a wide range of Ki's to be determined for ATP competitive ligands. Substituting Mn2+ for Mg2+ creates a paramagnetic probe (MnATP) from which the proximity of non-ATP competitive ligands can be inferred. Internal standards and references are used to reduce false positives due to protein or compound degradation. Use of the natural ATP ligand confers active site-specificity that is not available a priori from other ligand binding experiments.

摘要

ATP-STD核磁共振利用镁离子与ATP的结合来调节ATP对蛋白激酶的亲和力,从而能够测定一系列ATP竞争性配体的抑制常数(Ki)。用锰离子取代镁离子可产生顺磁探针(锰-ATP),由此可推断非ATP竞争性配体的接近程度。使用内标和参比物来减少因蛋白质或化合物降解导致的假阳性。使用天然ATP配体赋予了活性位点特异性,这是其他配体结合实验无法预先获得的。

相似文献

1
Screening of protein kinases by ATP-STD NMR spectroscopy.通过ATP-STD核磁共振光谱法筛选蛋白激酶。
J Am Chem Soc. 2005 Jun 8;127(22):7978-9. doi: 10.1021/ja0425942.
2
Novel synthesis and structural characterization of a high-affinity paramagnetic kinase probe for the identification of non-ATP site binders by nuclear magnetic resonance.新型高亲和力顺磁激酶探针的合成及结构表征,用于通过核磁共振鉴定非 ATP 结合位点配体。
J Med Chem. 2010 Feb 11;53(3):1238-49. doi: 10.1021/jm901525b.
3
Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors.嘌呤衍生物作为潜在ATP竞争性激酶抑制剂的合成及生物学测试
J Med Chem. 2005 Feb 10;48(3):710-22. doi: 10.1021/jm0408767.
4
Strategies for the NMR-based identification and optimization of allosteric protein kinase inhibitors.基于核磁共振的变构蛋白激酶抑制剂鉴定与优化策略。
Chembiochem. 2005 Sep;6(9):1607-10. doi: 10.1002/cbic.200500100.
5
kinDOCK: a tool for comparative docking of protein kinase ligands.kinDOCK:一种用于蛋白质激酶配体比较对接的工具。
Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W325-9. doi: 10.1093/nar/gkl211.
6
Pyruvate dehydrogenase kinase isoform 2 activity limited and further inhibited by slowing down the rate of dissociation of ADP.丙酮酸脱氢酶激酶同工型2的活性受到限制,并通过减缓ADP的解离速率而进一步受到抑制。
Biochemistry. 2004 Oct 26;43(42):13432-41. doi: 10.1021/bi049488x.
7
2-Fluoro-ATP as a versatile tool for 19F NMR-based activity screening.
J Am Chem Soc. 2008 May 7;130(18):5870-1. doi: 10.1021/ja801588u. Epub 2008 Apr 12.
8
Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening.蛋白激酶-抑制剂复合物的相互作用图谱及其在虚拟筛选中的应用
J Med Chem. 2005 Jan 13;48(1):121-33. doi: 10.1021/jm049312t.
9
Modeling kinase-substrate specificity: implication of the distance between substrate nucleophilic oxygen and attacked phosphorus of ATP analog on binding affinity.激酶-底物特异性建模:底物亲核氧与ATP类似物被攻击磷之间的距离对结合亲和力的影响。
J Mol Graph Model. 2005 Apr;23(5):433-8. doi: 10.1016/j.jmgm.2004.12.003. Epub 2005 Jan 20.
10
ATP-phosphopeptide conjugates as inhibitors of Src tyrosine kinases.ATP-磷酸肽偶联物作为Src酪氨酸激酶抑制剂
Bioorg Med Chem. 2004 Nov 15;12(22):5753-66. doi: 10.1016/j.bmc.2004.08.043.

引用本文的文献

1
Glycolytic oscillations under periodic drivings.周期性驱动下的糖酵解振荡。
J R Soc Interface. 2024 Feb;21(211):20230588. doi: 10.1098/rsif.2023.0588. Epub 2024 Feb 14.
2
Vitamin B modulates Parkinson's disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection.维生素 B 通过别构调节调节帕金森病 LRRK2 激酶活性并发挥神经保护作用。
Cell Res. 2019 Apr;29(4):313-329. doi: 10.1038/s41422-019-0153-8. Epub 2019 Mar 11.
3
Small molecule substrate phosphorylation site inhibitors of protein kinases: approaches and challenges.
蛋白激酶的小分子底物磷酸化位点抑制剂:方法与挑战
ACS Chem Biol. 2015 Jan 16;10(1):175-89. doi: 10.1021/cb5008376. Epub 2014 Dec 23.
4
Discovery and Hit-to-Lead Optimization of Non-ATP Competitive MK2 (MAPKAPK2) Inhibitors.非ATP竞争性MK2(丝裂原活化蛋白激酶激活蛋白激酶2)抑制剂的发现与苗头化合物到先导化合物的优化
ACS Med Chem Lett. 2011 Jun 24;2(8):632-7. doi: 10.1021/ml200113y. eCollection 2011 Aug 11.
5
Mitogen-activated protein kinases interacting kinases are autoinhibited by a reprogrammed activation segment.丝裂原活化蛋白激酶相互作用激酶被重新编程的激活片段自动抑制。
EMBO J. 2006 Sep 6;25(17):4020-32. doi: 10.1038/sj.emboj.7601285. Epub 2006 Aug 17.
6
Biomolecular NMR: a chaperone to drug discovery.生物分子核磁共振:药物发现的伴侣
Curr Opin Chem Biol. 2006 Jun;10(3):219-25. doi: 10.1016/j.cbpa.2006.04.006. Epub 2006 May 5.